Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

COVID symptoms this summer look a lot like symptoms from earlier strains, such as fatigue, runny nose and a headache. “The COVID symptoms that I’m seeing in clinic aren’t any different this year than ...

Hospitalists working in behavioral health centers face unique challenges, including limited resources and complex patient ...

The interview with Dr Asad Khan on long Covid (Solidarity 747-748) highlights the contribution to the growth in mental ill-health of widespread long Covid, which affects hundreds of millions of ...

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

Bay Area researchers created a group of AI “scientists” that proposed a potential COVID treatment. They say the approach ...

Yonker is a co-inventor on a patent for zonulin antagonists to treat MIS-C, as are two other co-authors. Co-authors also ...

In a small trial, Mass General Brigham researchers have found that a drug designed to treat celiac disease supported a more ...

There have been lots of changes to COVID vaccine recommendations. Here is the current vaccine schedule for people 6 months to 65+ years old.

Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.

Larazotide, a therapy known to treat celiac disease, shows promise as a safe treatment for multisystem inflammatory syndrome in children linked to COVID-19, enhancing recovery and symptom resolution.